Comparative Study of Chinese Hamster Ovary Cell Versus Escherichia coli‐Derived Bone Morphogenetic Protein‐2 Using the Critical‐Size Supraalveolar Peri‐Implant Defect Model
Authors:
- Eui Nam LeeELEui Nam Lee
- James YoonJYJames Yoon
- Sung‐Min ChungSCSung‐Min Chung
- Hari PrasadHPHari Prasad
- Cristiano SusinCSCristiano Susin
- Ulf M.E. WikesjöUWUlf M.E. Wikesjö
- 1 March 2013
- journal article
- research article
- Published by Wiley in Journal of Periodontology
- Vol. 84 (3) , 415-422
Abstract
Background: Chinese hamster ovary (CHO) cell‐derived recombinant human bone morphogenetic protein‐2 (rhBMP‐2) has been introduced for spine, long bone, and craniofacial indications. Escherichia coli‐ (E. coli) derived rhBMP‐2 displays comparable efficacy to CHO cell‐derived rhBMP‐2 in vitro and in small‐animal models. The objective of this study is to evaluate the efficacy of E. coli‐derived rhBMP‐2 compared to the benchmark CHO cell‐derived rhBMP‐2 using an established large‐animal model.Methods: Contralateral, critical‐size supraalveolar peri‐implant defects in six adult male Hound Labrador mongrel dogs received CHO cell‐ or E. coli‐derived rhBMP‐2 (0.2 mg/mL) in an absorbable collagen sponge (ACS) carrier. In each quadrant, three dental implants were placed. A titanium mesh device was used to support space provision. The animals received fluorescent bone markers for qualitative evaluations. Animals were euthanized at 8 weeks for histopathologic and histometric evaluation.Results: Clinical healing included significant swelling, but none of the animals experienced wound dehiscences. CHO cell‐ and E. coli‐derived rhBMP‐2 supported comparable bone formation (new bone area, 35.8 ± 3.6 versus 30.1 ± 2.2 mm2; bone density, 31.8% ± 1.6% versus 35.6% ± 2.5%; and osseointegration, 32.9% ± 7.4% versus 33.7% ± 8.1%) without statistically significant differences between treatments. Newly formed immature delicate trabecular bone in fibrovascular marrow filled the space underneath the titanium mesh and extended coronally above the mesh. Seroma formation was frequently observed. There were no discernable qualitative histologic differences between treatments.Conclusion: CHO cell‐ and E. coli‐derived rhBMP‐2 in an ACS carrier appear equally effective at inducing local bone formation in support of dental implant osseointegration.Keywords
This publication has 41 references indexed in Scilit:
- Effect of Escherichia coli-produced recombinant human bone morphogenetic protein 2 on the regeneration of canine segmental ulnar defectsJournal of Bone and Mineral Metabolism, 2011
- Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli‐expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: a radiographic and histologic analysisClinical Oral Implants Research, 2011
- Evaluation of Implants Coated With Recombinant Human Bone Morphogenetic Protein‐2 and Vacuum‐Dried Using the Critical‐Size Supraalveolar Peri‐Implant Defect Model in DogsJournal of Periodontology, 2010
- Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor‐5: histologic observationsJournal of Clinical Periodontology, 2010
- Evaluation of implants coated with rhBMP‐2 using two different coating strategies: a critical‐size supraalveolar peri‐implant defect study in dogsJournal of Clinical Periodontology, 2010
- Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein‐7 (rhBMP‐7/rhOP‐1): histological observationsJournal of Clinical Periodontology, 2010
- The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coliBiomaterials, 2010
- The critical‐size supraalveolar peri‐implant defect model: characteristics and useJournal of Clinical Periodontology, 2006
- Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2British Journal of Oral and Maxillofacial Surgery, 2000
- Recombinant Human Growth/Differentiation Factor 5 Stimulates Mesenchyme Aggregation and Chondrogenesis Responsible for the Skeletal Development of LimbsGrowth Factors, 1996